GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2006

Alligator Bioscience and AlgoNomics Ink Therapeutic Protein Partnership

  • Alligator Bioscience and AlgoNomics entered into a collaboration in which the latter will employ its Epibase® platform to complement the former in the optimization of therapeutic proteins both in their internal projects and in collaborative projects with customers.

    “All proteins delivered as biopharmaceuticals could render an immune response. For Alligator it is of great importance to make a responsible risk assessment on any new project. We are therefore grateful to be able to work with AlgoNomics, delivering a state-of-the-art technology, for investigating the theoretical consequence of an immune response,” states Gun-Britt Fransson, CEO of Alligator Bioscience.

    The collaboration allows Alligator to maximally reduce immunogenicity upon optimization of protein therapeutics with its ssDNA recombination technology FIND®.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »